From E*TRADE in my emails:
You have elected to receive securities information and submit your instructions
electronically. This e-mail contains information specific to your holding in the
securities identified below.
A TENDER OFFER for TRIUS THERAPEUTICS, INC. has been made
by BRGO CORPORATION.
The offer expires on September 11, 2013. You are required to reply
September 9, 2013 by 11:59 P.M. EST.
Personally I don't have a super large holding here and I don't want to shoulder any tax burden , so I think I am quite comfy holding pat as I think there is nothing but upside here as gravy. Really ...we are in a GREAT position...imho. . Good luck and AGTG!
2nd dat, affirmed
Jeff...by the same token, we look pretty resilient in the face of this volatility and I think dat speaks volumes. I have the feeling we are starting to get attention. We shall see.
This is pretty typical of how ATRS is attacked after earnings right now because we are very much underappreciated and you are looking at window shoppers. I could have easily told you to wait till today,..regardless don't let this disturb you at all.....as time passes the scoffers will WISH they had bought this little gem. You just hold those shares and frett not sir.
March 13, 2013
07:00 EDT TSRX Trius Therapeutics should be bought ahead of data, says Piper Jaffray
Piper Jaffray recommends buying shares of Trius Therapeutics ahead of the ESTABLISH-2 study data later this month. The firm expects positive data to drive Trius shares higher and views the company as a potential acquisition candidate. Piper keeps an Overweight rating on the stock with an $11 price target.
"Probably due to a inventory issue for the qtr. Some suppliers hold off ordering in the 4th qtr. Its just part of a normal business cycle"~~~ per whogo